{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T16:39:14Z","timestamp":1770136754507,"version":"3.49.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":13,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biol Eng"],"DOI":"10.1186\/s13036-026-00622-3","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T17:05:13Z","timestamp":1768928713000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Enhancing gene therapy vectors manufacturing: CEBPA as a master regulator of rAAV biogenesis"],"prefix":"10.1186","volume":"20","author":[{"given":"Filipa","family":"Moura","sequence":"first","affiliation":[]},{"given":"Mariana","family":"Antunes","sequence":"additional","affiliation":[]},{"given":"Ricardo","family":"Correia","sequence":"additional","affiliation":[]},{"given":"Ant\u00f3nio","family":"Rold\u00e3o","sequence":"additional","affiliation":[]},{"given":"Patr\u00edcia","family":"Gomes-Alves","sequence":"additional","affiliation":[]},{"given":"Paula Marques","family":"Alves","sequence":"additional","affiliation":[]},{"given":"Jose M.","family":"Escandell","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2026,1,20]]},"reference":[{"key":"622_CR1","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1016\/j.ymthe.2022.09.015","volume-title":"AAV vectors: the Rubik\u2019s cube of human gene therapy","author":"A Pupo","year":"2022","unstructured":"Pupo A, Fern\u00e1ndez A, Low SH, Fran\u00e7ois A, Su\u00e1rez-Amar\u00e1n L, Samulski RJ. AAV vectors: the Rubik\u2019s cube of human gene therapy. Molecular Therapy. Cell Press; 2022. p. 3515\u201341. https:\/\/doi.org\/10.1016\/j.ymthe.2022.09.015."},{"key":"622_CR2","doi-asserted-by":"publisher","unstructured":"Bulcha JT, Wang Y, Ma H, Tai PWL, Gao G. Viral vector platforms within the gene therapy landscape. In: Signal transduct target ther [Internet]. 6. Nature Publishing Group; 2021 [cited 2022 Dec 30]; https:\/\/doi.org\/10.1038\/S41392-021-00487-6.","DOI":"10.1038\/S41392-021-00487-6"},{"key":"622_CR3","doi-asserted-by":"publisher","unstructured":"Merten OW. Development of stable packaging and producer cell lines for the production of AAV vectors. Microorganisms [Internet]. Microorganisms; 2024 [cited 2024 Dec 3];12. https:\/\/doi.org\/10.3390\/MICROORGANISMS12020384.","DOI":"10.3390\/MICROORGANISMS12020384"},{"key":"622_CR4","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1146\/annurev-virology-031413-085355","volume":"1","author":"RJ Samulski","year":"2014","unstructured":"Samulski RJ, Muzyczka N. AAV-mediated gene therapy for research and therapeutic purposes. Annu Rev Virol. Annu Rev Inc. 2014;1:427\u201351. https:\/\/doi.org\/10.1146\/annurev-virology-031413-085355.","journal-title":"Annu Rev Virol. Annu Rev Inc"},{"key":"622_CR5","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/J.COPBIO.2021.12.009","volume":"74","author":"JM Escandell","year":"2022","unstructured":"Escandell JM, Pais DA, Carvalho SB, Vincent K, Gomes-Alves P, Alves PM. Leveraging rAAV bioprocess understanding and next generation bioanalytics development. Curr Opin Biotechnol. Elsevier Ltd. 2022;74:271\u201377. https:\/\/doi.org\/10.1016\/J.COPBIO.2021.12.009.","journal-title":"Curr Opin Biotechnol. Elsevier Ltd"},{"key":"622_CR6","doi-asserted-by":"publisher","first-page":"101266","DOI":"10.1016\/j.omtm.2024.101266","volume":"32","author":"W Xue","year":"2024","unstructured":"Xue W, Fulco C, Sha S, Alden N, Panteli J, Hossler P, et al. Adeno-associated virus perfusion enhanced expression: a commercially scalable, high titer, high quality producer cell line process. Mol Ther Methods Clin Dev [Internet]. 2024;32:101266. https:\/\/doi.org\/10.1016\/j.omtm.2024.101266. cited 2025 Mar 30","journal-title":"Mol Ther Methods Clin Dev"},{"key":"622_CR7","doi-asserted-by":"publisher","first-page":"521","DOI":"10.18609\/cgti.2016.067","volume-title":"AAV vector production: state of the art developments and remaining challenges. Cell gene Ther insights","author":"O-W Merten","year":"2016","unstructured":"Merten O-W. AAV vector production: state of the art developments and remaining challenges. Cell gene Ther insights. Vol. 2. BioInsights Publishing, Ltd; 2016. p. 521\u201351. https:\/\/doi.org\/10.18609\/cgti.2016.067."},{"key":"622_CR8","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1002\/bit.28394","volume-title":"Towards a scalable bioprocess for rAAV production using a HeLa stable cell line. Biotechnol Bioeng","author":"J Escandell","year":"2023","unstructured":"Escandell J, Moura F, Carvalho SB, Silva RJS, Correia R, Rold\u00e3o A, et al. Towards a scalable bioprocess for rAAV production using a HeLa stable cell line. Biotechnol Bioeng. Vol. 120. John Wiley and Sons Inc; 2023. p. 2578\u201387. https:\/\/doi.org\/10.1002\/bit.28394."},{"key":"622_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-45126-x","volume":"9","author":"AWT Chiang","year":"2019","unstructured":"Chiang AWT, Li S, Kellman BP, Chattopadhyay G, Zhang Y, Kuo CC, et al. Combating viral contaminants in CHO cells by engineering innate immunity. Sci Rep. 2019;9:1\u201315. https:\/\/doi.org\/10.1038\/s41598-019-45126-x.","journal-title":"Sci Rep"},{"key":"622_CR10","doi-asserted-by":"crossref","unstructured":"Abaandou L, Quan D, Shiloach J. Affecting HEK293 cell growth and production performance by modifying the expression of specific genes. 2021;1\u201321","DOI":"10.3390\/cells10071667"},{"key":"622_CR11","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1089\/hgtb.2019.123","volume":"30","author":"Y Wu","year":"2019","unstructured":"Wu Y, Mei T, Jiang L, Han Z, Dong R, Yang T, et al. Development of versatile and flexible Sf9 packaging cell line-dependent OneBac System for large-scale Recombinant adeno-associated virus production. Hum Gene Ther Methods. 2019;30:172\u201383. https:\/\/doi.org\/10.1089\/hgtb.2019.123.","journal-title":"Hum Gene Ther Methods"},{"key":"622_CR12","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.omtn.2021.06.026","volume-title":"Mol ther nucleic acids","author":"CR Barnes","year":"2021","unstructured":"Barnes CR, Lee H, Ojala DS, Lewis KK, Limsirichai P, Schaffer D V. Genome-wide activation screens to increase adeno-associated virus production. In: Mol ther nucleic acids [Internet]. 26. Cell Press; 2021. p. 94\u2013103. cited 2025 May 27. https:\/\/doi.org\/10.1016\/j.omtn.2021.06.026."},{"key":"622_CR13","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s41592-018-0048-5","volume-title":"Nat Methods","author":"NC Yeo","year":"2018","unstructured":"Yeo NC, Chavez A, Lance-Byrne A, Chan Y, Menn D, Milanova D, et al. An enhanced CRISPR repressor for targeted mammalian gene regulation. In: Nat Methods [Internet]. 15. Springer US; 2018. p. 611\u201316. cited 2019 Sep 3. https:\/\/doi.org\/10.1038\/s41592-018-0048-5."},{"key":"622_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41467-018-07901-8","volume-title":"Optimized libraries for CRISPR-Cas9 genetic screens with multiple modalities","author":"KR Sanson","year":"2018","unstructured":"Sanson KR, Hanna RE, Hegde M, Donovan KF, Strand C, Sullender ME, et al. Optimized libraries for CRISPR-Cas9 genetic screens with multiple modalities. Nat Commun. Nature Publishing Group; 2018. p. 9. https:\/\/doi.org\/10.1038\/s41467-018-07901-8."},{"key":"622_CR15","doi-asserted-by":"publisher","unstructured":"Wang C, Liu Y, Xiong J, Xie K, Wang T, Hu Y, et al. Genome-wide CRISPR screenings identified SMCHD1 as a host-restricting factor for AAV transduction. PLoS Pathog [Internet]. Public Library of Science; 2024 [cited 2025 May 27];20:e1012344. Available from: https:\/\/doi.org\/10.1371\/JOURNAL.PPAT.1012344.","DOI":"10.1371\/JOURNAL.PPAT.1012344"},{"key":"622_CR16","doi-asserted-by":"publisher","first-page":"101408","DOI":"10.1016\/J.OMTM.2025.101408","volume-title":"CRISPR screen reveals modifiers of rAAV production including known rAAV infection genes playing an unexpected role in vector production. Mol Ther Methods Clin Dev","author":"EE O\u2019Driscoll","year":"2025","unstructured":"O\u2019Driscoll EE, Arora S, Lang JF, Davidson BL, Shalem O. CRISPR screen reveals modifiers of rAAV production including known rAAV infection genes playing an unexpected role in vector production. Mol Ther Methods Clin Dev [Internet]. 33. Cell Press; 2025. p. 101408. cited 2025 May 27. https:\/\/doi.org\/10.1016\/J.OMTM.2025.101408."},{"key":"622_CR17","doi-asserted-by":"publisher","unstructured":"Fernandes S, Guerra J, Ferreira MV, Coroadinha AS. Deciphering key adenoviral elements in the production of Recombinant adeno-associated virus vectors. Hum Gene Ther [Internet]. Mary Ann Liebert Inc.; 2025 [cited 2025 Jun 9]; https:\/\/doi.org\/10.1089\/HUM.2024.265\/SUPPL_FILE\/HUM.2024.265_SUPPLEMENTARYFIGURES3.PDF.","DOI":"10.1089\/HUM.2024.265\/SUPPL_FILE\/HUM.2024.265_SUPPLEMENTARYFIGURES3.PDF"},{"key":"622_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/BIOINFORMATICS\/BTS635","author":"A Dobin","year":"2012","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics [Internet]. 2012. https:\/\/doi.org\/10.1093\/BIOINFORMATICS\/BTS635. cited 2025 Jul 14], 29, 15","journal-title":"Bioinformatics"},{"key":"622_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13059-014-0550-8\/FIGURES\/9","volume-title":"Genome Biol","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of Fold change and dispersion for RNA-seq data with DESeq2. In: Genome Biol [Internet]. 15. BioMed Central Ltd; 2014. p. 1\u201321. cited 2025 Jul 14. https:\/\/doi.org\/10.1186\/S13059-014-0550-8\/FIGURES\/9."},{"key":"622_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/bit.28925","volume-title":"Continuous production of influenza VLPs using IC-BEVS and Multi-stage bioreactors. Biotechnol Bioeng","author":"R Correia","year":"2025","unstructured":"Correia R, Zotler T, Ferraz F, Fernandes B, Gra\u00e7a M, Pijlman GP, et al. Continuous production of influenza VLPs using IC-BEVS and Multi-stage bioreactors. Biotechnol Bioeng. John Wiley and Sons Inc; 2025. https:\/\/doi.org\/10.1002\/bit.28925."},{"key":"622_CR21","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ymeth.2019.05.003","volume":"164-165","author":"V Tadi\u0107","year":"2019","unstructured":"Tadi\u0107 V, Josipovi\u0107 G, Zoldo\u0161 V, Vojta A. CRISPR\/Cas9-based epigenome editing: an overview of dCas9-based tools with special emphasis on off-target activity. Methods. 2019;164-165:109\u201319. https:\/\/doi.org\/10.1016\/j.ymeth.2019.05.003.","journal-title":"Methods"},{"key":"622_CR22","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/J.MOLP.2017.11.010","volume-title":"Robust transcriptional activation in plants using multiplexed CRISPR-Act2.0 and mTALE-act systems","author":"LG Lowder","year":"2018","unstructured":"Lowder LG, Zhou J, Zhang Y, Malzahn A, Zhong Z, Hsieh TF, et al. Robust transcriptional activation in plants using multiplexed CRISPR-Act2.0 and mTALE-act systems. Vol. 11. Mol Plant. Cell Press; 2018. p. 245\u201356. https:\/\/doi.org\/10.1016\/J.MOLP.2017.11.010."},{"key":"622_CR23","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1186\/S13059-014-0554-4","volume-title":"Genome Biol","author":"W Li","year":"2014","unstructured":"Li W, Xu H, Xiao T, Cong L, Love MI, Zhang F, et al. MAGeCK enables robust identification of essential genes from genome-scale CRISPR\/Cas9 knockout screens. In: Genome Biol [Internet]. 15. BioMed Central; 2014. p. 554. cited 2022 Oct 16. https:\/\/doi.org\/10.1186\/S13059-014-0554-4."},{"key":"622_CR24","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1532\/IJH97.05051\/METRICS","volume-title":"Int J Hematol","author":"S Koschmieder","year":"2005","unstructured":"Koschmieder S, Rosenbauer F, Steidl U, Owens BM, Tenen DG. Role of transcription factors C\/EBP\u03b1 and PU.1 in normal hematopoiesis and leukemia. In: Int J Hematol [Internet]. 81. Springer; 2005. p. 368\u201377. cited 2025 Jul 8. https:\/\/doi.org\/10.1532\/IJH97.05051\/METRICS."},{"key":"622_CR25","doi-asserted-by":"publisher","unstructured":"Zhao X, Reebye V, Hitchen P, Fan J, Jiang H, S\u00e6trom P, et al. Mechanisms involved in the activation of C\/EBP\u03b1 by small activating RNA in hepatocellular carcinoma. In: Oncogene 2019, 38: 18 [Internet]. Nature Publishing Group; 38. 2019 [cited 2025 Aug 2]; p. 3446\u201357. https:\/\/doi.org\/10.1038\/s41388-018-0665-6.","DOI":"10.1038\/s41388-018-0665-6"},{"key":"622_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/S41375-023-01989-8","volume-title":"Leukemia","author":"MP Garcia-Cuellar","year":"2023","unstructured":"Garcia-Cuellar MP, Akan S, Slany RK. A C\/ebp\u03b1 isoform specific differentiation program in immortalized myelocytes. In: Leukemia [Internet]. Springer Nature; 2023. cited 2025 Jun 17], 37, 1850. https:\/\/doi.org\/10.1038\/S41375-023-01989-8."},{"key":"622_CR27","doi-asserted-by":"publisher","first-page":"108017","DOI":"10.1016\/J.BIOTECHADV.2022.108017","volume-title":"Biotechnol Adv","author":"J Lavado-Garc\u00eda","year":"2022","unstructured":"Lavado-Garc\u00eda J, P\u00e9rez-Rubio P, Cervera L, G\u00f2dia F. The cell density effect in animal cell-based bioprocessing: questions, insights and perspectives. In: Biotechnol Adv [Internet]. 60. Elsevier; 2022. p. 108017. cited 2025 Jul 10. https:\/\/doi.org\/10.1016\/J.BIOTECHADV.2022.108017."},{"key":"622_CR28","doi-asserted-by":"publisher","first-page":"316508","DOI":"10.3389\/FIMMU.2017.01908\/PDF","volume-title":"Front immunol","author":"C Xia","year":"2018","unstructured":"Xia C, Braunstein Z, Toomey AC, Zhong J, Rao X. S100 proteins as an important regulator of macrophage inflammation. In: Front immunol [Internet]. 8. Frontiers Media S.A; 2018. p. 316508. cited 2025 Mar 31. https:\/\/doi.org\/10.3389\/FIMMU.2017.01908\/PDF."},{"key":"622_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/CELLS9010094","author":"X Chen","year":"2019","unstructured":"Chen X, Cao R, Zhong W. Host calcium channels and pumps in viral infections. Cells [Internet]. MDPI. 2019. https:\/\/doi.org\/10.3390\/CELLS9010094. cited 2025 Apr 2], 9, 94","journal-title":"Cells [Internet]. MDPI"},{"key":"622_CR30","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.1002\/1873-3468.13696","volume-title":"Innate immunity to adenovirus: lessons from mice","author":"S Atasheva","year":"2019","unstructured":"Atasheva S, Yao J, Shayakhmetov DM. Innate immunity to adenovirus: lessons from mice. FEBS Lett. Wiley Blackwell; 2019. p. 3461\u201383. https:\/\/doi.org\/10.1002\/1873-3468.13696."},{"key":"622_CR31","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.immuni.2009.04.015","volume":"31","author":"NC Di Paolo","year":"2009","unstructured":"Di Paolo NC, Miao EA, Iwakura Y, Murali-Krishna K, Aderem A, Flavell RA, et al. Virus binding to a plasma membrane receptor triggers interleukin-1\u03b1-mediated proinflammatory macrophage response in vivo. Immunity. 2009;31:110\u201321. https:\/\/doi.org\/10.1016\/j.immuni.2009.04.015.","journal-title":"Immunity"},{"key":"622_CR32","doi-asserted-by":"publisher","unstructured":"Barber GN. Innate immune DNA sensing pathways: STING, AIMII and the regulation of interferon production and inflammatory responses. Curr Opin Immunol. 2011;10\u201320. https:\/\/doi.org\/10.1016\/j.coi.2010.12.015.","DOI":"10.1016\/j.coi.2010.12.015"},{"key":"622_CR33","doi-asserted-by":"publisher","unstructured":"Motwani M, Pesiridis S, Fitzgerald KA. DNA sensing by the cGAS-STING pathway in health and disease. Nat Rev Genet. Nat Publishing Group. 2019;657\u201374. https:\/\/doi.org\/10.1038\/s41576-019-0151-1.","DOI":"10.1038\/s41576-019-0151-1"},{"key":"622_CR34","doi-asserted-by":"publisher","first-page":"3358","DOI":"10.1038\/S41388-023-02846-9","volume-title":"Oncogene","author":"E Molina","year":"2023","unstructured":"Molina E, Garc\u00eda-Guti\u00e9rrez L, Junco V, Perez-Olivares M, de Y\u00e9benes VG, Blanco R, et al. MYC directly transactivates CR2\/CD21, the receptor of the Epstein-Barr virus, enhancing the viral infection of Burkitt lymphoma cells. In: Oncogene [Internet]. 42. Oncogene; 2023. p. 3358\u201370. cited 2025 Apr 1. https:\/\/doi.org\/10.1038\/S41388-023-02846-9."},{"key":"622_CR35","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/EJH.12450","volume-title":"Eur J Haematol","author":"HY Li","year":"2015","unstructured":"Li HY, Deng DH, Huang Y, Ye FH, Huang LL, Xiao Q, et al. Favorable prognosis of biallelic CEBPA gene mutations in acute myeloid leukemia patients: a meta-analysis. In: Eur J Haematol [Internet]. 94. Blackwell Publishing Ltd; 2015. p. 439\u201348. cited 2025 Jun 5. https:\/\/doi.org\/10.1111\/EJH.12450."},{"key":"622_CR36","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.1002\/1873-3468.12702","volume-title":"FEBS Lett","author":"IG Schulman","year":"2017","unstructured":"Schulman IG. Liver X receptors link lipid metabolism and inflammation. In: FEBS Lett [Internet]. 591. John Wiley & Sons, Ltd; 2017. p. 2978\u201391. cited 2025 Apr 2. https:\/\/doi.org\/10.1002\/1873-3468.12702."},{"key":"622_CR37","doi-asserted-by":"publisher","first-page":"59, 2287","DOI":"10.1194\/JLR.M084558","volume-title":"J Lipid Res","author":"Y Liu","year":"2018","unstructured":"Liu Y, Wei Z, Zhang Y, Ma X, Chen Y, Yu M, et al. Activation of liver X receptor plays a central role in antiviral actions of 25-hydroxycholesterol. In: J Lipid Res [Internet]. American Society for Biochemistry and Molecular Biology Inc; 2018. p. 59, 2287. cited 2025 Apr 2. https:\/\/doi.org\/10.1194\/JLR.M084558."},{"key":"622_CR38","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.omtm.2024.101266","volume-title":"Adeno-associated virus perfusion enhanced expression: a commercially scalable, high titer, high quality producer cell line process. Mol Ther Methods Clin Dev","author":"W Xue","year":"2024","unstructured":"Xue W, Fulco C, Sha S, Alden N, Panteli J, Hossler P, et al. Adeno-associated virus perfusion enhanced expression: a commercially scalable, high titer, high quality producer cell line process. Mol Ther Methods Clin Dev. Cell Press; 2024. p. 32. https:\/\/doi.org\/10.1016\/j.omtm.2024.101266."},{"key":"622_CR39","doi-asserted-by":"publisher","first-page":"1020174","DOI":"10.3389\/FBIOE.2022.1020174\/BIBTEX","volume":"10","author":"JP Mendes","year":"2022","unstructured":"Mendes JP, Fernandes B, Pineda E, Kudugunti S, Bransby M, Gantier R, et al. AAV process intensification by perfusion bioreaction and integrated clarification. Front Bioeng Biotechnol. Front Media S.A. 2022;10:1020174. https:\/\/doi.org\/10.3389\/FBIOE.2022.1020174\/BIBTEX.","journal-title":"Front Bioeng Biotechnol. Front Media S.A"}],"container-title":["Journal of Biological Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13036-026-00622-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13036-026-00622-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13036-026-00622-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T16:43:30Z","timestamp":1770050610000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13036-026-00622-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,20]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["622"],"URL":"https:\/\/doi.org\/10.1186\/s13036-026-00622-3","relation":{},"ISSN":["1754-1611"],"issn-type":[{"value":"1754-1611","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,20]]},"assertion":[{"value":"29 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors Filipa Moura, Mariana Antunes, Patr\u00edcia Gomes-Alves, Paula Marques Alves, and Jose Miguel Escandell are co-inventors on a provisional patent application (No. 119768) related to sequences targeting the gene\n                      CEBPA\n                      , which was identified as a key gene in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24"}}